Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

Private equity-backed Medline files for IPO
The company, founded in 1966, has been providing supplies to cardiac surgery suites and cath labs for decades.
Key takeaways for interventional cardiology from TCT 2025
B. Hadley Wilson, MD, talked to Cardiovascular Business about several standout late-breaking clinical trials presented at TCT 2025. Topics of those trials included drug-coated balloons, TAVR valve durability, pulmonary embolism treatments and much more.
More good news for renal denervation: FDA-approved systems linked to positive long-term data
New data on the RDN systems from Recor Medical and Medtronic confirmed that this relatively new technology brings long-term relief to patients with uncontrolled hypertension.
Nearly 600K bottles of blood pressure drug recalled due to carcinogen risk
The FDA has detailed three voluntary recalls for prazosin hydrochloride, a medication used to treat hypertension, due to safety concerns.
Patient sues Abbott after early heart valve replacement
The patient's Trifecta GT heart valve had to be replaced after just six years, an experience he says resulted in "permanent injuries." Abbott pulled the devices off the U.S. market in 2023 due to a known risk of structural valve deterioration.

Severe financial strain more than doubles risk of death among heart attack patients

Screening for financial strain, researchers wrote, could help identify patients who need additional help.

How modified bioprosthetic heart valves could limit calcification, reduce need for TAVR

Bioprosthetic heart valves often express foreign sugars that trigger a response from the body's immune system. This immune response appears to be associated with calcification.

Omicron COVID variant slammed hospitals in January

The surge in the omicron COVID-19 variant slammed the financial health of hospitals and health systems during the first month of 2022.

Researchers review PCI outcomes, find little evidence of a ‘July effect’ in interventional cardiology

New trainees may not necessarily lead to a higher risk of medical errors during PCI.

Examples of CT imaging showing aortic dissections on an acute AAA response team app that was recently cleared by the FDA from Viz.AI.

FDA Roundup: AAA EVAR recommendations, key approvals in stroke care and interventional cardiology

The FDA has been busy, sharing recommendations and clearing solutions that could have a significant impact on cardiovascular care throughout the United States.

How COVID-19 vaccination affects the risk of ED visits for cardiac, respiratory issues

The study's authors said their research “further highlights the effectiveness of the COVID-19 vaccine overall.”

The Edwards Lifesciences Sapien transcatheter aortic valve replacement (TAVR) device in a heart model used to show patients how the device works.

TAVR associated with lower healthcare costs than surgery

Researchers examined Medicare data from 2016 to 2018, presenting their findings in Circulation: Cardiovascular Interventions.

Patient demand for telemedicine remains strong

Clinicians and health systems have had more time to optimize their telemedicine practices, contributing to an increase in telemedicine’s overall favorability among patients, according to a report by Doximity.

Clinical

Private equity-backed Medline files for IPO

Key takeaways for interventional cardiology from TCT 2025

More good news for renal denervation: FDA-approved systems linked to positive long-term data

Nearly 600K bottles of blood pressure drug recalled due to carcinogen risk

Patient sues Abbott after early heart valve replacement